I Am Just a Support Teacher

　　 The press conference lasted until the afternoon.

　　 Mainly some official media reporters want to confirm whether what Tian Jiajia said is true.

　　 To this end, CCTV reporters also connected a well-known AIDS expert to ask Tian Jiajia a question.

　　 They are afraid that this incident will be reported without the authenticity of it. If what Tian Jiajia said is false, then China will be embarrassed in front of the whole world.

　　 But even so, after the interview, many official media dare not believe that Tian Jiajia has really developed an AIDS drug based on the test videos and experimental data provided by Tian Jiajia.

Therefore, after the press conference, some non-official media reported the incident one after another, while most mainstream official media, such as CCTV, only reported that Tian Jiajia might have developed a specific AIDS medicine. Further investigation is needed.

　　 The official media reported that this incident was relatively conservative, but even so, Tian Jiajia's research on HIV-specific drugs spread all over the Chinese Internet in one night.

　　 But abroad, this incident did not cause any disturbances.

　　 After several foreign media reported the incident, more media immediately rebutted it.

　　 Finally, several media that reported the news also apologized, saying that the news was untrue.

　　 In such a situation, as long as it is a slightly smarter person, you can guess that these companies must have touched the interests of some people, and then they have been suppressed.

　　 The day after Yang Xin and Tian Jiajia held the press conference, Tian Jiajia was contacted by an official person who wanted to investigate and confirm the authenticity of the AIDS drug.

The country attaches great importance to this matter. There are more than 40 million AIDS patients in the world, and China has only one million. If China has a specific AIDS medicine, then this medicine is not just a medicine, but has risen to politics. Level.

　　Like artemisinin, this medicine has played a big role in maintaining the friendly relations between China and Africa.

　　On the second day of the press conference, Tian Jiajia returned to the capital again.

　　 In the next period of time, she will need to do the animal experiment again with a group of AIDS experts.

　　 As long as the effects of specific drugs on animals can be proved, as Tian Jiajia said at the press conference, then the country will immediately approve Tian Jiajia's drugs for human clinical trials.

　　 At that time, the country will also open a special green channel for review, so that this drug will be listed as soon as possible.

　　 It is good that medicines can be marketed as soon as possible, but the raw materials for making AIDS specific medicines are very scarce-such as the kind of high-altitude herbs and the kind of medicinal materials produced in Siberia.

　　 Therefore, the most urgent task is to artificially cultivate the raw materials as soon as possible during the drug review stage.

　　In this way, only after the approval of the drug’s marketing approval will the raw materials be used to produce the drug.

　　 Yang Xin's side, he rejected the idea of ​​letting Tian Jiajia take a stake in Hexin Pharmaceutical Company, and that Hexin Pharmaceutical Company would invest in the medicinal planting base.

　　 After all, Hexin Pharmaceutical Company has other shareholders. If Tian Jiajia uses this medicine to buy shares, wouldn't it be cheaper for others?

　　 So the two decided, he and Tian Jiajia, and both parties invested one billion yuan to establish a new pharmaceutical company.

In the new pharmaceutical company, Tian Jiajia took up 60% of the shares with the results of AIDS specific drugs, and Yang Xin, with the results of neutralizing the toxicity of Changshan, plus the investment of 1 billion, accounted for the remaining 40%. Shares.

　　 The prescription for neutralizing Changshan's toxicity was exchanged by Yang Xin for 300 points from the system mall, so this is his personal achievement, and Hetian Jiajia’s research results are separate.

　　 After all, one yard is one yard, he can't give this result to Tian Jiajia for nothing.

　　 If he hadn't exchanged this thing, Tian Jiajia hadn't even thought about researching out AIDS drugs in a few years.

　　 Therefore, it is only natural that he will get 40% of the company's shares with the result of the exchange of 300 points.

　　————

　　 After the press conference, many media reported on Tian Jiajia’s development of AIDS drugs.

　　 However, the authenticity of the AIDS drug is still under investigation. All netizens across the country are looking forward to the findings of the expert group.

　　This investigation was carried out by several national biological laboratories. Tian Jiajia provided finished HIV-specific drugs to several biological laboratories, and the laboratory would find rhesus monkeys and chimpanzees with HIV to test the drugs.

　　 If the medicine is real and effective, then I believe there will be results soon.

　　 In the expectation of netizens, in less than half a month, there was good news from a national key biological laboratory.

　　In the experiment, three macaques and two chimpanzees slightly infected with HIV were all killed after half a month of different doses of medicine.

　　 Just after the results of this laboratory came out, good news soon came from several other laboratories, and it finally proved that this AIDS drug is really effective.

　　 The next day, the Central News Network officially released the news to the people of the whole country.

　　 At the same time, the People’s Daily also published this news on all major platforms. Congratulations to Tian Jiajia for her achievements ~www.ltnovel.com~ and thank her for bringing hope to AIDS patients.

　　 With the voices of the two largest official media, other media immediately began to reprint or publish their own press releases.

　　 On this day, countless media have reported this news one after another.

　　 "Teacher, the Food and Drug Administration has approved the clinical trial of this drug."

　　 On this day, Tian Jiajia called Yang Xin and told him good news.

　　 "That's good, do you continue to follow up the clinical trial or leave it to the company?" Yang Xin asked Tian Jiajia.

　　 The two have established a three-port pharmaceutical company, and Yang Xin asked He Qingqing to recruit a group of people directly from major pharmaceutical companies to form the company team.

　　 The president of this company is also temporarily held by He Qingqing, who will be handed over to professional managers when the company is on the right track.

　　 "Leave it to the company, the medicine has been researched out, as long as there are no major problems, I am not going to intervene, I am going to continue researching new drugs." Tian Jiajia said to Yang Xin.

　　 "Research on new drugs? Which aspect?" Yang Xin asked curiously.

　　 "Let’s study the tumor!"

　　 Tian Jiajia said: "At present, among the five terminal illnesses, rheumatoid, leukemia and AIDS have cures and drugs, but there are still many cancers that cannot be cured, so I want to start with cancer." Tian Jiajia said to Yang Xin.

　　 "Okay, ambitious, the teacher supports you." Yang Xin encouraged.

　　 Speaking of cancer, Yang’s mother’s lung cancer was cured by Yang Xin, but the method of treating cancer is too expensive for ordinary people to cure.

　　 And that method later proved that the success rate was very low. Whether Yang’s mother was able to save it or luck accounted for the majority, this treatment method could not be widely promoted.